Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction

Journal of Heart and Lung Transplantation

Volumn 35, Issue 11, 2016, Pages 1348-1357

  Reich, Heidi ^a   Tseliou, Eleni ^a   de Couto, Geoffrey ^a   Angert, David ^a   Valle, Jackelyn ^a   Kubota, Yuzu ^a   Luthringer, Daniel ^a   Mirocha, James ^a   Sun, Baiming ^a   Smith, Rachel R ^b   Marbán, Linda ^a,b   Marbán, Eduardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Capricor   (United States)

Author keywords

cardiosphere derived cells; cell therapy; regenerative medicine; regneration; stem cells

Indexed keywords

ALLOANTIBODY; SODIUM CHLORIDE;

ALLOGENEIC CARDIOSPHERE DERIVED CELL TRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CARDIAC STEM CELL; CELLULAR IMMUNITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOASSAY; INFLAMMATORY INFILTRATE; ISOGRAFT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPEAT PROCEDURE; SENSITIZATION; THORACOTOMY; TRANSTHORACIC ECHOCARDIOGRAPHY; WISTAR KYOTO RAT; XENOGRAFT; ANIMAL; BIOLOGICAL THERAPY; CARDIAC MUSCLE CELL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; GRAFT REJECTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; IMMUNIZATION; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GRAFT REJECTION; IMMUNIZATION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, INBRED BN; RATS, INBRED WKY; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84994424481     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.05.008     Document Type: Article

References (32)

1. 1 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–322.
2. 2 Li, T.S., Cheng, K., Malliaras, K., et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59 (2012), 942–953.
3. 3 Bergmann, O., Bhardwaj, R.D., Bernard, S., et al. Evidence for cardiomyocyte renewal in humans. Science 324 (2009), 98–102.
4. 4 Chimenti, I., Smith, R.R., Li, T.S., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106 (2010), 971–980.
5. 5 Malliaras, K., Zhang, Y., Seinfeld, J., et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med 5 (2013), 191–209.
6. 6 Malliaras, K., Ibrahim, A., Tseliou, E., et al. Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med 6 (2014), 760–777.
7. 7 Makkar, R.R., Smith, R.R., Cheng, K., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379 (2012), 895–904.
8. 8 Malliaras, K., Makkar, R.R., Smith, R.R., et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 63 (2014), 110–122.
9. 9 Lauden, L., Boukouaci, W., Borlado, L.R., et al. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. Circ Res 112 (2013), 451–464.
10. 10 Malliaras, K., Li, T.S., Luthringer, D., et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125 (2012), 100–112.
11. 11 ALLSTAR. Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration. https://clinicaltrials.gov/ct2/show/NCT01458405/. Accessed June 2, 2015.
12. 12 DYNAMIC. Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells. https://clinicaltrials.gov/ct2/show/NCT02293603/. Accessed June 2, 2015.
13. 13 HOPE-Duchenne. Halt cardiOmyopathy ProgrEssion (HOPE) in Duchenne muscular dystrophy. https://clinicaltrials.gov/ct2/show/NCT02485938/. Accessed June 8, 2016.
14. 14 Stewart, R., Butcher, G., Herbert, J., et al. Graft rejection in a congenic panel of rats with defined immune response genes for MHC class I antigens. I. Rejection of and priming to the RT1Aa antigen. Transplantation 40 (1985), 427–432.
15. 15 Murata, K., Iwata, T., Nakashima, S., et al. C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation. Transplantation 86 (2008), 123–129.
16. 16 Smith, R.R., Barile, L., Cho, H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007), 896–908.
17. 17 Messina, E., De Angelis, L., Frati, G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004), 911–921.
18. 18 Shen, D., Cheng, K., Marban, E., Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med 16 (2012), 2112–2116.
19. 19 Bersell, K., Arab, S., Haring, B., et al. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138 (2009), 257–270.
20. 20 Stewart, S., Winters, G.L., Fishbein, M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005), 1710–1720.
21. 21 Quah, B.J., Warren, H.S., Parish, C.R., Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2 (2007), 2049–2056.
22. 22 Kim, I., Wu, G., Chai, N.N., et al. Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization. Transplantation 98 (2014), 1262–1270.
23. 23 Tseliou, E., Pollan, S., Malliaras, K., et al. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. J Am Coll Cardiol 61 (2013), 1108–1119.
24. 24 Yoshida, K., Gould, K.L., Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 22 (1993), 984–997.
25. 25 Richardson, J.D., Psaltis, P.J., Frost, L., et al. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction. Cytotherapy 16 (2014), 460–470.
26. 26 Ankrum, J.A., Ong, J.F., Karp, J.M., Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32 (2014), 252–260.
27. 27 Zangi, L., Margalit, R., Reich-Zeliger, S., et al. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 27 (2009), 2865–2874.
28. 28 Nauta, A.J., Westerhuis, G., Kruisselbrink, A.B., et al. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108 (2006), 2114–2120.
29. 29 Badillo, A.T., Beggs, K.J., Javazon, E.H., et al. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant 13 (2007), 412–422.
30. 30 Camp, D.M., Loeffler, D.A., Farrah, D.M., et al. Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease. J Neuroinflammation, 6, 2009, 17.
31. 31 Boukouaci, W., Lauden, L., Siewiera, J., et al. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovasc Res 104 (2014), 290–302.
32. 32 Malliaras, K., Zhang, Y., Seinfeld, J., et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med 5 (2013), 191–209.